INTEGRA LIFESCIENCES HOLDINGS CORP (IART)
About INTEGRA LIFESCIENCES HOLDINGS CORP
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and Tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales. The company operates in United States, Europe, Asia Pacific, and Rest of the World.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $1.6B
- Net income
- -$516.5M
- Total assets
- $3.6B
- Market cap
- $1.3B
- Gross margin
- 50.9%
- Operating margin
- -30.2%
- Net margin
- -31.6%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $1.6B
- Cost of revenue
- $803.6M
- Gross profit
- $831.6M
- Operating expenses
- $1.3B
- Operating income
- -$493.4M
- Income tax
- -$47.0M
- Net income
- -$516.5M
- EPS (basic)
- $-6.74
- EPS (diluted)
- $-6.74
Balance sheet
- Total assets
- $3.6B
- Current assets
- $1.2B
- Total liabilities
- $2.6B
- Current liabilities
- $456.0M
- Shareholders’ equity
- $1.0B
Cash flow
- Operating cash flow
- $50.4M
- Investing cash flow
- -$108.1M
- Financing cash flow
- $28.3M
- Net cash flow
- -$11.3M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $1.3B
- EPS (diluted)
- $-6.74
- Shares outstanding
- 66.8M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Aug 16, 1995
Integra Lifesciences Holdings Corp (IART) Stock Price
- Reported a net loss of $516.5M in FY2025.
- Revenue grew 6% from FY2021 to FY2025.
- Gross margin of 50.9%, net margin -31.6%.
- Trading near its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review INTEGRA LIFESCIENCES HOLDINGS CORP.
Write a review
News about INTEGRA LIFESCIENCES HOLDINGS CORP
News & sentiment via Polygon.io
Integra Lifesciences Holdings Corp: frequently asked questions
Is Integra Lifesciences Holdings Corp an American company?
Integra Lifesciences Holdings Corp is a US-based company headquartered in Princeton, New Jersey, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Integra Lifesciences Holdings Corp headquartered?
Integra Lifesciences Holdings Corp is headquartered in Princeton, New Jersey, United States.
Is Integra Lifesciences Holdings Corp publicly traded?
Yes — Integra Lifesciences Holdings Corp is a publicly traded company. Its stock trades under the ticker symbol IART on the NASDAQ.
What does Integra Lifesciences Holdings Corp do?
Integra Lifesciences Holdings Corp is an American Medical Devices company in the Health & Beauty sector.
When was Integra Lifesciences Holdings Corp founded?
Integra Lifesciences Holdings Corp was founded in 1989.
